Head and neck cancer
A Trial Evaluating Omission of Radiotherapy to Regional Lymphatic's
Who can joinAdults
Age18–70 years
Kind of studyPhase 3: compared with usual treatment
What it testsRadiation and a medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Where to go
1 hospital in India taking patients for this trial.
Nci, AiimsJhajjar, HaryanaDirections ↗
Registry summary (technical)
The present study is a phase II/III prospective randomized trial designed to determine whether eliminating of post operative radiotherapy to regional lymphatics in pN0-N1oral cavity is associated with similar treatment outcomes.
Sponsor: All India Institute of Medical Sciences
NCT07528495 on ClinicalTrials.gov
Last updated on the registry 6 May 2026 · read by us 20 Oct 2026